Padelli, M.; Desterke, C.; Devocelle, A.; Clay, D.; Bourillon, A.; Uzan, G.; Lemoine, A.; Giron-Michel, J.
Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma. Cells 2026, 15, 961.
https://doi.org/10.3390/cells15110961
AMA Style
Padelli M, Desterke C, Devocelle A, Clay D, Bourillon A, Uzan G, Lemoine A, Giron-Michel J.
Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma. Cells. 2026; 15(11):961.
https://doi.org/10.3390/cells15110961
Chicago/Turabian Style
Padelli, Maël, Christophe Desterke, Aurore Devocelle, Denis Clay, Agnès Bourillon, Georges Uzan, Antoinette Lemoine, and Julien Giron-Michel.
2026. "Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma" Cells 15, no. 11: 961.
https://doi.org/10.3390/cells15110961
APA Style
Padelli, M., Desterke, C., Devocelle, A., Clay, D., Bourillon, A., Uzan, G., Lemoine, A., & Giron-Michel, J.
(2026). Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma. Cells, 15(11), 961.
https://doi.org/10.3390/cells15110961
